Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This is prospective, randomized study. The purpose of this study is to evaluate whether the addition of Suzetrigine to well established multimodal pain regimen for participants undergoing bariatric patients undergoing weight-loss surgery and cardiac patients undergoing sternotomy will reduce post-operative opioid consumption and pain scores.
Epistemonikos ID: cd67aef9a2fdbd5461f9dfad776d4eb876b18f2e
First added on: Apr 21, 2026